NCT01235416 2011-01-21
A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors
Amgen
Phase 1 Completed
Clinical Trials
1 trialsHistologically or Cytologically Documented Solid Tumors × motesanib diphosphate × Other solid neoplasm × Clear all